Transcat, Inc (NASDAQ:TRNS) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.
On May 16, 2017, Transcat, Inc. (the Company) issued a press
release announcing its financial results for its fiscal year 2017
fourth quarter and year ended March 25, 2017. The press release
is attached to this Form 8-K as Exhibit 99.1.
In addition, on May 17, 2017, the Company posted slides to the
Investor Relations section of its website that will accompany the
Companys earnings conference call and webcast at 11:00 a.m.
Eastern Time on May 17, 2017. The slides are attached to this
Form 8-K as Exhibit 99.2.
The information furnished to this Item 2.02, including Exhibits
99.1 and 99.2, shall not be deemed filed for purposes of Section
18 of the Securities Exchange Act of 1934, as amended (the
Exchange Act) or otherwise subject to the liabilities under such
section and shall not be deemed to be incorporated by reference
into any filing of the Company under the Securities Act of 1933,
as amended, or the Exchange Act.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description | ||
| 99.1 | Transcat, Inc. Press Release dated May 16, 2017 | ||
| 99.2 |
Slides for the May 17, 2017 Earnings Conference Call and Webcast |
About Transcat, Inc (NASDAQ:TRNS)
Transcat, Inc. is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak). Through its Distribution segment, the Company markets, sells and rents national brand instruments to customers around the globe. The Company is focused on providing its services and products to the life science industries, which include pharmaceutical, biotechnology, medical device manufacturing and other Food and Drug Administration (FDA)-regulated businesses. Transcat, Inc (NASDAQ:TRNS) Recent Trading Information
Transcat, Inc (NASDAQ:TRNS) closed its last trading session 00.00 at 12.35 with 6,462 shares trading hands.
